Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA PDMP CTRPv2 pan-cancer AAC 0.083 0.03
mRNA prima-1 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA FSC231 CTRPv2 pan-cancer AAC 0.15 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.04
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.069 0.04
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.083 0.04
Download CSV